Veracyte (VCYT) Tops Q4 EPS by 1c

Veracyte (NASDAQ: VCYT) reported Q4 EPS of ($0.29), $0.01 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $14 million versus the consensus estimate of $14.45 million.

GUIDANCE:

Veracyte sees FY2016 revenue of $59-63 million, versus the consensus of $62.9 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Construction Partners, Inc. (ROAD) Tops Q3 EPS by 1c ; Offers Guidance
• Gyre Therapeutics (GYRE) Misses Q2 EPS by 6c
• National Healthcare (NHC) Tops Q2 EPS by 174c